MINOR GENETIC DETERMINANTS OF SECOND-LINE INJECTION DRUGS RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
- Authors: Jou R.1,2,3, Kulagina E.V.4, Lee W.T.1,2, Nosova E.Y.5, Weng J.Y.1,2, Antonova O.V.4, Lin W.H.1,2, Isakova A.I.5, Wu M.H.1,2, Zimenkov D.V.4
 - 
							Affiliations: 
							
- Tuberculosis Research Center, Taiwan Centers for Disease Control, Taipei
 - Diagnostics and Vaccine Center, Taiwan Centers for Disease Control, Taipei
 - Institute of Microbiology and Immunology, National Yang-Ming University, Taipei
 - Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
 - Moscow Research and Clinical Center for Tuberculosis Control, Moscow
 
 - Issue: Vol 8, No 4 (2018)
 - Pages: 571
 - Section: TUBERCULOSIS AND MYCOBACTERIA: MOLECULAR APPROACH
 - Submitted: 11.01.2019
 - Accepted: 11.01.2019
 - Published: 30.12.2018
 - URL: https://iimmun.ru/iimm/article/view/1019
 - DOI: https://doi.org/10.15789/2220-7619-2018-4-6.24
 - ID: 1019
 
Cite item
Full Text
Abstract
About the authors
R. Jou
Tuberculosis Research Center, Taiwan Centers for Disease Control, Taipei; Diagnostics and Vaccine Center, Taiwan Centers for Disease Control, Taipei; Institute of Microbiology and Immunology, National Yang-Ming University, Taipei
							Author for correspondence.
							Email: fake@neicon.ru
				                					                																			                												                	Тайвань													
E. V. Kulagina
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
														Email: fake@neicon.ru
				                					                																			                												                	Россия													
W. T. Lee
Tuberculosis Research Center, Taiwan Centers for Disease Control, Taipei; Diagnostics and Vaccine Center, Taiwan Centers for Disease Control, Taipei
														Email: fake@neicon.ru
				                					                																			                												                	Тайвань													
E. Yu. Nosova
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
														Email: fake@neicon.ru
				                					                																			                												                	Россия													
J. Y. Weng
Tuberculosis Research Center, Taiwan Centers for Disease Control, Taipei; Diagnostics and Vaccine Center, Taiwan Centers for Disease Control, Taipei
														Email: fake@neicon.ru
				                					                																			                												                	Тайвань													
O. V. Antonova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
														Email: fake@neicon.ru
				                					                																			                												                	Россия													
W. H. Lin
Tuberculosis Research Center, Taiwan Centers for Disease Control, Taipei; Diagnostics and Vaccine Center, Taiwan Centers for Disease Control, Taipei
														Email: fake@neicon.ru
				                					                																			                												                	Тайвань													
A. I. Isakova
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
														Email: fake@neicon.ru
				                					                																			                												                	Россия													
M. H. Wu
Tuberculosis Research Center, Taiwan Centers for Disease Control, Taipei; Diagnostics and Vaccine Center, Taiwan Centers for Disease Control, Taipei
														Email: fake@neicon.ru
				                					                																			                												                	Тайвань													
D. V. Zimenkov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
														Email: fake@neicon.ru
				                					                																			                												                	Россия													
Supplementary files
				
			
					
						



